Rating History for Cellectar Biosciences (CLRB) by Brookline Capital Markets
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 7/13/2026 | Kumaraguru Raja | New Coverage | Buy (N/A) |
15.00 (N/A) |
2.77 (2.51) |
-9.39% | Details |
 |
|||||||
|
|||||||
